Suppr超能文献

常驻记忆 T 细胞与癌症。

Resident memory T cells and cancer.

机构信息

Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN 55455, USA; Center for Immunology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

Department of Microbiology and Immunology, University of Minnesota Medical School, Minneapolis, MN 55455, USA; Center for Immunology, University of Minnesota Medical School, Minneapolis, MN 55455, USA; Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

出版信息

Immunity. 2024 Aug 13;57(8):1734-1751. doi: 10.1016/j.immuni.2024.06.017.

Abstract

Tissue-resident memory T (T) cells positively correlate with cancer survival, but the anti-tumor mechanisms underlying this relationship are not understood. This review reconciles these observations, summarizing concepts of T cell immunosurveillance, fundamental T cell biology, and clinical observations on the role of T cells in cancer and immunotherapy outcomes. We also discuss emerging strategies that utilize T-phenotype cells for patient diagnostics, staging, and therapy. Current challenges are highlighted, including a lack of standardized T cell nomenclature and our limited understanding of relationships between T cell markers and underlying tumor biology. Existing findings are integrated into a summary of the field while emphasizing opportunities for future research.

摘要

组织驻留记忆 T(T)细胞与癌症存活呈正相关,但尚不清楚这种关系背后的抗肿瘤机制。本综述调和了这些观察结果,总结了 T 细胞免疫监视、T 细胞基本生物学以及 T 细胞在癌症和免疫治疗结果中的作用的临床观察。我们还讨论了利用 T 表型细胞进行患者诊断、分期和治疗的新兴策略。突出了当前的挑战,包括缺乏标准化的 T 细胞命名法以及我们对 T 细胞标志物与潜在肿瘤生物学之间关系的理解有限。将现有研究结果整合到该领域的总结中,同时强调未来研究的机会。

相似文献

1
Resident memory T cells and cancer.
Immunity. 2024 Aug 13;57(8):1734-1751. doi: 10.1016/j.immuni.2024.06.017.
8
CCR5-mediated dynamic maintenance of resident memory T cells in the respiratory tract.
Sci China Life Sci. 2025 May 30. doi: 10.1007/s11427-024-2920-y.

引用本文的文献

3
Tissue-Resident Memory T Cells in Cancer Metastasis Control.
Cells. 2025 Aug 21;14(16):1297. doi: 10.3390/cells14161297.
6
Ageing, immune fitness and cancer.
Nat Rev Cancer. 2025 Aug 14. doi: 10.1038/s41568-025-00858-z.
7
T cells in cancer: mechanistic insights and therapeutic advances.
Biomark Res. 2025 Jul 15;13(1):97. doi: 10.1186/s40364-025-00807-w.
10
KLF2 inhibition expands tumor-resident T cells and enhances tumor immunity.
Res Sq. 2025 Mar 13:rs.3.rs-5966555. doi: 10.21203/rs.3.rs-5966555/v1.

本文引用的文献

1
Personalized neoantigen vaccine and pembrolizumab in advanced hepatocellular carcinoma: a phase 1/2 trial.
Nat Med. 2024 Apr;30(4):1044-1053. doi: 10.1038/s41591-024-02894-y. Epub 2024 Apr 7.
2
Metabolic waypoints during T cell differentiation.
Nat Immunol. 2024 Feb;25(2):206-217. doi: 10.1038/s41590-023-01733-5. Epub 2024 Jan 18.
3
Therapeutic cancer vaccines: advancements, challenges, and prospects.
Signal Transduct Target Ther. 2023 Dec 13;8(1):450. doi: 10.1038/s41392-023-01674-3.
4
Prevention of respiratory virus transmission by resident memory CD8 T cells.
Nature. 2024 Feb;626(7998):392-400. doi: 10.1038/s41586-023-06937-1. Epub 2023 Dec 12.
5
CD8+CD103+PD1+TIM3+ T cells in glioblastoma microenvironment correlate with prognosis.
Immunology. 2024 Feb;171(2):198-211. doi: 10.1111/imm.13710. Epub 2023 Oct 26.
6
The tumor-draining lymph node as a reservoir for systemic immune surveillance.
Trends Cancer. 2024 Jan;10(1):28-37. doi: 10.1016/j.trecan.2023.09.006. Epub 2023 Oct 18.
7
Stem-like exhausted and memory CD8 T cells in cancer.
Nat Rev Cancer. 2023 Nov;23(11):780-798. doi: 10.1038/s41568-023-00615-0. Epub 2023 Oct 11.
8
CD8 T cells in the cancer-immunity cycle.
Immunity. 2023 Oct 10;56(10):2231-2253. doi: 10.1016/j.immuni.2023.09.005.
9
ZNF683 marks a CD8 T cell population associated with anti-tumor immunity following anti-PD-1 therapy for Richter syndrome.
Cancer Cell. 2023 Oct 9;41(10):1803-1816.e8. doi: 10.1016/j.ccell.2023.08.013. Epub 2023 Sep 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验